LEONARDI, LUCA Statistiche
LEONARDI, LUCA
Analysis of fatal adverse drug events recorded in several Italian emergency departments (the MEREAFaPS study)
2021-01-01 Pagani, S.; Lombardi, N.; Crescioli, G.; Vighi, G. V.; Spada, G.; Romoli, I.; Andreetta, P.; Capuano, A.; Marrazzo, E.; Marra, A.; Leoni, O.; Vannacci, A.; Venegoni, M.; Vighi, G. D.; Bettoni, D.; Blandizzi, C.; Bonaiuti, R.; Borsi, V.; Cecchi, E.; Convertino, I.; Del Lungo, M.; Di Mauro, C.; Farina, G.; Ferraro, S.; Fucile, A.; Galfrascoli, E.; Geninatti, E.; Giovannetti, L.; Leonardi, L.; Liccardo, R.; Monina, G.; Mugelli, A.; Pagani, S.; Parrilli, M.; Rafaniello, C.; Rossi, F.; Rostan, S.; Ruocco, M.; Sironi, M.; Sportiello, L.; Tuccori, M.
Utilisation patterns and clinical impact of the introduction of infliximab-biosimilar in Tuscany, Italy: real world evidence following the recommendation of switching for non-medical reasons
2021-01-01 Convertino, Irma; Lucenteforte, Ersilia; Gini, Rosa; Lorenzoni, Valentina; Cazzato, Massimiliano; Turchetti, Giuseppe; Trieste, Leopoldo; Ferraro, Sara; Leonardi, Luca; Roberto, Giuseppe; Luciano, Nicoletta; Blandizzi, Corrado; Mosca, Marta; Tuccori, Marco
Risk of hospitalisation associated with benzodiazepines and z-drugs in Italy: a nationwide multicentre study in emergency departments
2020-01-01 Lombardi, N.; Bettiol, A.; Crescioli, G.; Ravaldi, C.; Bonaiuti, R.; Venegoni, M.; Vighi, G. D.; Mugelli, A.; Mannaioni, G.; Vannacci, A.; Aiezza, M. L.; Bettoni, D.; Blandizzi, C.; Borsi, V.; Capuano, A.; Cecchi, E.; Convertino, I.; Lungo, M. D.; Mauro, C. D.; Farina, G.; Ferraro, S.; Fucile, A.; Galfrascoli, E.; Geninatti, E.; Giovannetti, L.; Leonardi, L.; Liccardo, R.; Marra, A.; Marrazzo, E.; Monina, G.; Pagani, S.; Parrilli, M.; Rafaniello, C.; Rossi, F.; Rossi, M.; Rostan, S.; Ruocco, M.; Sironi, M.; Spada, G.; Sportiello, L.; Tuccori, M.; Vighi, G. V.
Anti-tumor Necrosis Factor Drugs and Risk of Lymphoma in Patients with Inflammatory Bowel Disease
2019-01-01 Blandizzi, C; Tuccori, M; Ferraro, S; Leonardi, L; Convertino, I
Antibiotic Drugs and Unresolved Sensory Side Effects: Analysis of Eudravigilance Database of Suspected Adverse Drug Reaction Reports
2019-01-01 Ferraro, S; Leonardi, L; Blandizzi, C; Convertino, I; Tuccori, M
Anticoagulant Therapy and Risk of Bleeding in Patients with Atrial Fibrillation of Four Italian Regions: The TYRION Study
2019-01-01 Convertino, I; Leonardi, L; Tuccori, M; Ferraro, S; Salvadori, S; Franchini, M; De Carlo, I; Kirchmayer, U; Corona, T; Riengler, S; Menditto, E; Parrilli, M; Rossi, M; Orlando, V; Pieroni, S; Vannacci, A
Listening Social Media for Pharmacovigilance Objectives: Which Usefulness?
2019-01-01 Convertino, I; Leonardi, L; Tuccori, M; Ferraro, S; Blandizzi, C
Recommendations by the Tuscan Health Authority to Use Infliximab-Biosimilar in the Clinical Practice: Safety Impact
2019-01-01 Convertino, I; Lucenteforte, E; Lorenzoni, V; Turchetti, G; Trieste, L; Roberto, G; Cazzato, M; Mosca, M; Ferraro, S; Leonardi, L; Luciano, N; Gini, R; Blandizzi, C; Tuccori, M
Switching from infliximab-originator to infliximab-biosimilar in rheumatologic patients: The clinical impact in Tuscan Region, Italy
2019-01-01 Convertino, I; Tuccori, M; Lucenteforte, E; Mosca, M; Turchetti, G; Lorenzoni, V; Trieste, L; Ferraro, S; Leonardi, L; Roberto, G; Luciano, N; Blandizzi, C; Gini, R
THE ECONOMIC IMPACT OF THE INTRODUCTION OF INFLIXIMAB-BIOSIMILAR: AN EMPIRICAL ANALYSIS USING THE TUSCANY HEALTHCARE ADMINISTRATIVE DATABASES
2019-01-01 Lorenzoni, V; Convertino, I; Lucenteforte, E; Ferraro, S; Leonardi, L; Roberto, G; Luciano, N; Cazzato, M; Blandizzi, C; Gini, R; Tuccori, M; Mosca, M; Turchetti, G
The Economic Impact of the Introduction of Infliximab-Biosimilar: Preliminary Results from a Study on Rheumatologic Patients in Tuscany, Italy
2019-01-01 Lorenzoni, V; Trieste, L; Mosca, M; Convertino, I; Tuccori, M; Lucenteforte, E; Ferraro, S; Leonardi, L; Roberto, G; Luciano, N; Blandizzi, C; Gini, R; Turchetti, G
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Analysis of fatal adverse drug events recorded in several Italian emergency departments (the MEREAFaPS study) | 1-gen-2021 | Pagani, S.; Lombardi, N.; Crescioli, G.; Vighi, G. V.; Spada, G.; Romoli, I.; Andreetta, P.; Capuano, A.; Marrazzo, E.; Marra, A.; Leoni, O.; Vannacci, A.; Venegoni, M.; Vighi, G. D.; Bettoni, D.; Blandizzi, C.; Bonaiuti, R.; Borsi, V.; Cecchi, E.; Convertino, I.; Del Lungo, M.; Di Mauro, C.; Farina, G.; Ferraro, S.; Fucile, A.; Galfrascoli, E.; Geninatti, E.; Giovannetti, L.; Leonardi, L.; Liccardo, R.; Monina, G.; Mugelli, A.; Pagani, S.; Parrilli, M.; Rafaniello, C.; Rossi, F.; Rostan, S.; Ruocco, M.; Sironi, M.; Sportiello, L.; Tuccori, M. | |
| Utilisation patterns and clinical impact of the introduction of infliximab-biosimilar in Tuscany, Italy: real world evidence following the recommendation of switching for non-medical reasons | 1-gen-2021 | Convertino, Irma; Lucenteforte, Ersilia; Gini, Rosa; Lorenzoni, Valentina; Cazzato, Massimiliano; Turchetti, Giuseppe; Trieste, Leopoldo; Ferraro, Sara; Leonardi, Luca; Roberto, Giuseppe; Luciano, Nicoletta; Blandizzi, Corrado; Mosca, Marta; Tuccori, Marco | |
| Risk of hospitalisation associated with benzodiazepines and z-drugs in Italy: a nationwide multicentre study in emergency departments | 1-gen-2020 | Lombardi, N.; Bettiol, A.; Crescioli, G.; Ravaldi, C.; Bonaiuti, R.; Venegoni, M.; Vighi, G. D.; Mugelli, A.; Mannaioni, G.; Vannacci, A.; Aiezza, M. L.; Bettoni, D.; Blandizzi, C.; Borsi, V.; Capuano, A.; Cecchi, E.; Convertino, I.; Lungo, M. D.; Mauro, C. D.; Farina, G.; Ferraro, S.; Fucile, A.; Galfrascoli, E.; Geninatti, E.; Giovannetti, L.; Leonardi, L.; Liccardo, R.; Marra, A.; Marrazzo, E.; Monina, G.; Pagani, S.; Parrilli, M.; Rafaniello, C.; Rossi, F.; Rossi, M.; Rostan, S.; Ruocco, M.; Sironi, M.; Spada, G.; Sportiello, L.; Tuccori, M.; Vighi, G. V. | |
| Anti-tumor Necrosis Factor Drugs and Risk of Lymphoma in Patients with Inflammatory Bowel Disease | 1-gen-2019 | Blandizzi, C; Tuccori, M; Ferraro, S; Leonardi, L; Convertino, I | |
| Antibiotic Drugs and Unresolved Sensory Side Effects: Analysis of Eudravigilance Database of Suspected Adverse Drug Reaction Reports | 1-gen-2019 | Ferraro, S; Leonardi, L; Blandizzi, C; Convertino, I; Tuccori, M | |
| Anticoagulant Therapy and Risk of Bleeding in Patients with Atrial Fibrillation of Four Italian Regions: The TYRION Study | 1-gen-2019 | Convertino, I; Leonardi, L; Tuccori, M; Ferraro, S; Salvadori, S; Franchini, M; De Carlo, I; Kirchmayer, U; Corona, T; Riengler, S; Menditto, E; Parrilli, M; Rossi, M; Orlando, V; Pieroni, S; Vannacci, A | |
| Listening Social Media for Pharmacovigilance Objectives: Which Usefulness? | 1-gen-2019 | Convertino, I; Leonardi, L; Tuccori, M; Ferraro, S; Blandizzi, C | |
| Recommendations by the Tuscan Health Authority to Use Infliximab-Biosimilar in the Clinical Practice: Safety Impact | 1-gen-2019 | Convertino, I; Lucenteforte, E; Lorenzoni, V; Turchetti, G; Trieste, L; Roberto, G; Cazzato, M; Mosca, M; Ferraro, S; Leonardi, L; Luciano, N; Gini, R; Blandizzi, C; Tuccori, M | |
| Switching from infliximab-originator to infliximab-biosimilar in rheumatologic patients: The clinical impact in Tuscan Region, Italy | 1-gen-2019 | Convertino, I; Tuccori, M; Lucenteforte, E; Mosca, M; Turchetti, G; Lorenzoni, V; Trieste, L; Ferraro, S; Leonardi, L; Roberto, G; Luciano, N; Blandizzi, C; Gini, R | |
| THE ECONOMIC IMPACT OF THE INTRODUCTION OF INFLIXIMAB-BIOSIMILAR: AN EMPIRICAL ANALYSIS USING THE TUSCANY HEALTHCARE ADMINISTRATIVE DATABASES | 1-gen-2019 | Lorenzoni, V; Convertino, I; Lucenteforte, E; Ferraro, S; Leonardi, L; Roberto, G; Luciano, N; Cazzato, M; Blandizzi, C; Gini, R; Tuccori, M; Mosca, M; Turchetti, G | |
| The Economic Impact of the Introduction of Infliximab-Biosimilar: Preliminary Results from a Study on Rheumatologic Patients in Tuscany, Italy | 1-gen-2019 | Lorenzoni, V; Trieste, L; Mosca, M; Convertino, I; Tuccori, M; Lucenteforte, E; Ferraro, S; Leonardi, L; Roberto, G; Luciano, N; Blandizzi, C; Gini, R; Turchetti, G |